Project cooperationUpdated on 22 January 2026
Allogeneic Cell therapy of cancer an autoimmune diseases
Principal Investigator at IRCCS Azienda Ospedaliera Metropolitana, plesso Ospedale Policlinico San Martino
Genova, Italy
About
-Development and validation of off-the-shelf cell therapies
-Multi-omics data available for deep characterization and identification of target gene to implement safety and efficacy
-Standardization of manufacturing
-Pre-clinical and clinical grade manufacturing
-In vitro and in vivo models
-expertise in cancer vaccines and their combination with other therapies
-genomic profile of cancer stem cells and their susceptibility to cell therapy
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Attached files
Similar opportunities
Project cooperation
New in vitro assay methodologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Hanne Haslene-Hox
Seinor research scientist at SINTEF Industry
Trondheim, Norway
Project cooperation
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Vladan Čokić
Head of Department of molecular oncology at Institute for Medical Research University of Belgrade
Belgrade, Serbia
Project cooperation
Seeking collaboration in ATMP and New Approach Methodologies
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
Grzegorz Chodaczek
Immunotherapy Group Leader at Łukasiewicz Research Network - PORT Polish Center for Technology Development
Wrocław, Poland